BlackRock Health Sciences Term Trust (NYSE:BMEZ) Major Shareholder Saba Capital Management, L.P. Purchases 2,006 Shares (2024)

BlackRock Health Sciences Term Trust (NYSE:BMEZ - Get Free Report) major shareholder Saba Capital Management, L.P. purchased 2,006 shares of the stock in a transaction on Monday, September 23rd. The shares were purchased at an average cost of 15.98 per share, with a total value of 32,055.88. Following the transaction, the insider now owns 20,603,574 shares in the company, valued at approximately 329,245,112.52. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Large shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

On Thursday, September 19th, Saba Capital Management, L.P. purchased 15,455 shares of BlackRock Health Sciences Term Trust stock. The shares were purchased at an average cost of 16.14 per share, with a total value of 249,443.70.
On Tuesday, September 17th, Saba Capital Management, L.P. acquired 27,148 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average price of 15.93 per share, with a total value of 432,467.64.

BlackRock Health Sciences Term Trust Trading Down 1.2 %

NYSE BMEZ opened at 15.83 on Wednesday. The stock has a 50-day simple moving average of 15.84 and a two-hundred day simple moving average of 15.54. BlackRock Health Sciences Term Trust has a fifty-two week low of 12.93 and a fifty-two week high of 16.59.

BlackRock Health Sciences Term Trust Dividend Announcement

America’s new currency (check your wallet)

From Stansberry Research | Ad

A new currency could soon start circulating all over America.It's already being issued by certain major financial institutions, though you may not have realized it yet.

Here's everything you need to know, including the #1 move I recommend

The business also recently disclosed a monthly dividend, which will be paid on Thursday, October 31st. Shareholders of record on Tuesday, October 15th will be paid a dividend of $0.176 per share. The ex-dividend date is Tuesday, October 15th. This represents a $2.11 dividend on an annualized basis and a dividend yield of 13.34%.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

A number of institutional investors have recently modified their holdings of BMEZ. PNC Financial Services Group Inc. raised its stake in shares of BlackRock Health Sciences Term Trust by 17.7% during the 4th quarter. PNC Financial Services Group Inc. now owns 30,559 shares of the company's stock valued at $448,000 after buying an additional 4,604 shares during the last quarter. Pine Valley Investments Ltd Liability Co raised its stake in shares of BlackRock Health Sciences Term Trust by 6.7% during the 4th quarter. Pine Valley Investments Ltd Liability Co now owns 13,088 shares of the company's stock valued at $192,000 after buying an additional 822 shares during the last quarter. Weiss Asset Management LP purchased a new position in shares of BlackRock Health Sciences Term Trust in the 4th quarter valued at about $2,669,000. Oppenheimer & Co. Inc. increased its stake in shares of BlackRock Health Sciences Term Trust by 2.0% in the 4th quarter. Oppenheimer & Co. Inc. now owns 76,699 shares of the company's stock valued at $1,124,000 after purchasing an additional 1,536 shares in the last quarter. Finally, Quantedge Capital Pte Ltd increased its stake in shares of BlackRock Health Sciences Term Trust by 47.5% in the 4th quarter. Quantedge Capital Pte Ltd now owns 375,026 shares of the company's stock valued at $5,494,000 after purchasing an additional 120,800 shares in the last quarter.

BlackRock Health Sciences Term Trust Company Profile

(Get Free Report)

BlackRock Health Sciences Trust II’s (BMEZ) (the 'Trust') investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [emailprotected].

Insider Buying or Selling at BlackRock Health Sciences Term Trust?

Sign-up to receive InsiderTrades.com's daily insider buying and selling report for BlackRock Health Sciences Term Trust and related companies.